The U.S. Trade Representative, Robert Lighthizer, has rejected the EU’s proposed cancellation of tariffs on pharmaceuticals globally as “really, really crazy”. Yet, COVID-19 will likely keep pressure on healthcare supply chains for several months yet, particularly if there is a continued surge in cases in the U.S. Seaborne imports of pharmaceuticals to the U.S. rose by 16.8% year over year in May and the first half of June combined. Imports of personal protective equipment meanwhile have surged with a 378.1% jump led by imports of face masks rising 11.6-fold. There may be issues with ven...
Copyright © 2025 Panjiva Supply Chain Intelligence, a product offering from S&P Global Market Intelligence Inc. All rights reserved.




